DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Armand P, Shipp MA, Ribrag V, Michot JM, Zinzani PL, Kuruvilla J. et al.
Programmed Death-1 blockade with pembrolizumab in patients with classical Hodgkin lymphoma after brentuximab vedotin failure.
J Clin Oncol 2016;
34: 3733-9
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.